Skip to main content
Premium Trial:

Request an Annual Quote

GeneSpring GX 9.0, GenCLiP, Progeniq

Agilent Technologies has released GeneSpring GX 9.0. The new version of the visualization and analysis system for gene expression data is built on the Avadis platform developed by Strand Life Sciences and includes new “guided workflow” features for several commercial microarray platforms, the company said.
GeneSpring GX 9.0 includes guided workflows for Agilent SurePrint microarrays, Affymetrix GeneChips, and Illumina Beadchips, with additional applications planned. The workflows guide researchers through the analysis steps required for each platform, the company said.
The new version of GeneSpring can also be used to highlight enriched pathways or gene ontology categories. The software supports the BioPAX pathways/network exchange format and lets users import networks and pathways from sources such as KEGG, the Cancer Cell Map, and BioCyc.

The Cancer Institute at Southern Medical University has released GenCLiP (Genes Cluster with Literature Profiles), a software program for clustering gene lists by literature profiling and constructing gene co-occurrence networks related to custom keywords. According to the developers, the software can create a primary pathogenesis profile for a special disease and identify pathways involving abnormally expressed genes not previously associated with the disease. GenCLiP is available here.

Progeniq has launched BioBoost v4.0, a hardware-accelerated appliance for performing Blast, Smith-Waterman, HMMer, and ClustalW searches. BioBoost is based on field-programmable gate array technology. The new version offers up to 50-fold acceleration and consumes less energy than a CPU cluster, the company said.

Filed under

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.